VERTESS Achieves Top Ranking in Healthcare M&A Advisory

VERTESS Leading the Way in Healthcare M&A Advisory
VERTESS, a prominent advisory firm specializing in healthcare mergers and acquisitions (M&A), has recently been recognized as the top lower middle market sell-side M&A advisor on Axial's 2024 Healthcare Top 50 list. This prestigious acknowledgment highlights VERTESS's proficiency in navigating complex transactions and its commitment to delivering exceptional results for its clients.
Axial Recognition: A Testimony to Excellence
Axial, a private deal network that connects professionals who own, advise, and invest in businesses across North America, selected VERTESS based on its remarkable performance over the past year. The Healthcare Top 50 list features advisors who have demonstrated exceptional activity and effectiveness in facilitating transactions across various sectors within the healthcare industry. VERTESS's impressive number of deals and the interest generated within the Axial network contributed to its top ranking, showcasing its vital role in the healthcare M&A landscape.
Welcoming Christine Bartel as Managing Director
VERTESS is excited to announce the addition of Christine M. Bartel to its leadership team as Managing Director. With nearly three decades of healthcare experience, Christine has held pivotal roles in administration and executive leadership, focusing on clinical compliance, care coordination, and operational efficiencies, especially in financial growth strategies. Her extensive background equips her with a unique understanding of the industry's challenges and opportunities.
Christine's Journey in Healthcare
Before joining VERTESS, Christine founded Hope at Home, Inc. and Aspire Home Care, both successful healthcare firms. As CEO, she managed over 350 caregivers and expanded the companies across Colorado, ultimately selling them to a private equity firm in 2008. Following the sale, she established a consulting practice, helping underperforming healthcare entities enhance their capabilities and achieve sustainable growth through strategic guidance and operational improvements.
Education and Achievements
Christine's academic background is impressive; she holds a bachelor's degree in economics with a premedical emphasis from the University of Colorado Boulder and an MBA in healthcare administration from George Washington University. Her professional accolades include several prestigious awards, such as the Corporate Social Responsibility/Bronze Stevie Award and recognition on the Inc. 5000 list of fastest-growing private companies.
Transforming Healthcare Leadership
Christine emphasizes her passion for assisting healthcare leaders in navigating the complexities of their operations. She believes that her experience as a hands-on provider of healthcare services allows her to offer valuable insights to those seeking to enhance their organizations. Her decision to join VERTESS stems from a shared commitment to empowering clients through M&A processes that facilitate success.
Focused on Client Success
Vaughne Glennie, Managing Partner of VERTESS, commended Christine's dedication and the unique perspective she brings to the table. Having successfully built two healthcare companies herself, Christine's commitment to improving individual patient care remains steadfast. She advocates that with the right knowledge, educational outreach, and sufficient resources, healthcare providers can achieve remarkable outcomes.
Looking Ahead
As VERTESS continues to lead in healthcare M&A advisory, the addition of experienced professionals like Christine Bartel will undoubtedly strengthen its capability to meet the evolving needs of the healthcare sector. VERTESS aims to provide not only transactional support but also strategic insights that empower healthcare organizations to thrive in a competitive environment.
About VERTESS
VERTESS is an international healthcare-focused Mergers & Acquisitions (M&A) advisory firm, offering expertise across a wide range of healthcare and human service sectors. From behavioral health to pharmacies and home care services, VERTESS's team of seasoned professionals ensures that every client receives personalized attention and strategic advice aimed at achieving successful outcomes.
Frequently Asked Questions
What is VERTESS known for?
VERTESS is recognized as a leading healthcare M&A advisory firm, specializing in lower middle market transactions.
Who is Christine Bartel?
Christine Bartel is the newly appointed Managing Director at VERTESS, bringing nearly 30 years of healthcare experience to the team.
What did VERTESS achieve on Axial's list?
VERTESS was named the #1 lower middle market sell-side M&A advisor on Axial's 2024 Healthcare Top 50 list.
What sectors does VERTESS cover?
VERTESS provides expertise across various healthcare sectors, including behavioral health, home care, and pharmacies.
How does VERTESS support healthcare leaders?
VERTESS helps healthcare leaders through M&A advisory, operational guidance, and strategic planning to enhance their organizations' growth.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.